{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"abri-amyloidosis","columns":[{"gene":"","key":"population-0dcaeacf5f53763525c2","label":"Cerebral amyloid angiopathy, itm2b-related, 1","mondoId":"MONDO:0008306","onsetQualifier":null,"originColumnKey":"MONDO:0008306/OMIM:176500","originalViews":[{"key":"MONDO:0008306/OMIM:176500","label":"Cerebral amyloid angiopathy, itm2b-related, 1","scopeLabel":"OMIM:176500","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["15aa9be4e64ad102c0175ce7fd69fb7bd618b57c28a496f0d5f4d56f3442a06f","265ed96508892b98d83edf3413c2d1baff19b86bf63872adc33c0a6fe0240186","4c3c45580e6fb60b980694eece70b550f9d0a8db2b41086ba497667b2d2eb22f","6f08183c3d5521dc1e9bc7ce23cb28839323905f0dd9450de6a4bc7f30e50950","96868213aef50d4da1c124d720d7cb63ede2eb8d42765460ee32b6af4c5da7b6","b86dcc4e8623f2ae3c016dbfc26bb3c87b9b34d0f020520c295eca27f47454ae","cfdf0c7df94f849c19aa83e2e161c21d5cc1acbe3155cc2b6c060203be352617"],"recordQualifiers":{},"scopeLabel":"OMIM:176500","sourceIds":["OMIM:176500"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-0dcaeacf5f53763525c2"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0011970","HP:0000726","HP:0001276","HP:0002344","HP:0002063","HP:0001257","HP:0001337"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":7,"sourceGroups":{"omim":7}},"features":[{"hpoId":"HP:0011970","label":"Cerebral amyloid angiopathy","primary":true},{"hpoId":"HP:0000726","label":"Dementia","primary":true},{"hpoId":"HP:0001276","label":"Hypertonia","primary":true},{"hpoId":"HP:0002344","label":"Progressive neurologic deterioration","primary":true},{"hpoId":"HP:0002063","label":"Rigidity","primary":true},{"hpoId":"HP:0001257","label":"Spasticity","primary":true},{"hpoId":"HP:0001337","label":"Tremor","primary":true}],"ledeHtml":"A cerebral amyloid angiopathy characterized by onset in the 4th to 6th decade of life, progressive mental deterioration, spasticity, muscular rigidity but no tremors, spontaneous movements or sensory changes that has material basis in an autosomal dominant mutation of ITM2B on chromosome 13q14.2.","mondoId":"MONDO:0008306","node":{"canonicalSlug":"abri-amyloidosis","comparisons":[{"documentSha256":"5364d4f9514526e17810712c4ecca2e7bbf032d0d1e84caaabc16b6f5db22578","key":"legacy-abri-amyloidosis","kind":"legacy","label":"ABri amyloidosis","memberIds":["MONDO:0008306"],"mondoId":"MONDO:0008306","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/abri-amyloidosis.5364d4f9514526e17810712c4ecca2e7bbf032d0d1e84caaabc16b6f5db22578.json"},{"documentSha256":"4748dda3b4e7321cf829138b3671ad88cffd3ea01a5ff26d552cc9a4570b8da4","key":"expanded-cerebral-amyloid-angiopathy","kind":"expanded","label":"cerebral amyloid angiopathy","memberIds":["MONDO:0005620","MONDO:0007098","MONDO:0007297","MONDO:0008306","MONDO:0011583","MONDO:0015033","MONDO:0017945","MONDO:0017946","MONDO:0017947","MONDO:0017948","MONDO:0017949"],"mondoId":"MONDO:0005620","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-4748dda3b4e7321cf829.4748dda3b4e7321cf829138b3671ad88cffd3ea01a5ff26d552cc9a4570b8da4.json"},{"documentSha256":"f2ce26ec83a58c0f7fb9534a5454cda38cbfcf2bfb80f65ae3cd02dc6b9b8a20","key":"expanded-itm2b-amyloidosis","kind":"expanded","label":"ITM2B amyloidosis","memberIds":["MONDO:0007297","MONDO:0008306","MONDO:0018591"],"mondoId":"MONDO:0018591","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-f2ce26ec83a58c0f7fb9.f2ce26ec83a58c0f7fb9534a5454cda38cbfcf2bfb80f65ae3cd02dc6b9b8a20.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"ABri amyloidosis","originalSourceId":"ORPHA:97345","paragraphs":["A cerebral amyloid angiopathy characterized by onset in the 4th to 6th decade of life, progressive mental deterioration, spasticity, muscular rigidity but no tremors, spontaneous movements or sensory changes that has material basis in an autosomal dominant mutation of ITM2B on chromosome 13q14.2."],"rawAttribution":"MONDO:0008306","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:06:16Z","upstream":"MONDO:0008306","url":"https://rarediseases.info.nih.gov/diseases/8344"},"ownColumnKeys":["population-0dcaeacf5f53763525c2"],"publication":"published","relationships":[{"kind":"parent","label":"cerebral amyloid angiopathy","mondoId":"MONDO:0005620","slug":"cerebral-amyloid-angiopathy"},{"kind":"parent","label":"ITM2B amyloidosis","mondoId":"MONDO:0018591","slug":"itm2b-amyloidosis"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"multiple-identity-targets","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/hereditary-cerebral-amyloid-angiopathy"}],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"15aa9be4e64ad102c0175ce7fd69fb7bd618b57c28a496f0d5f4d56f3442a06f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:176500","disease_name":"Cerebral amyloid angiopathy, itm2b-related, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001337","is_excluded":false,"label":"Tremor","onset_id":null,"reference":"OMIM:176500","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"265ed96508892b98d83edf3413c2d1baff19b86bf63872adc33c0a6fe0240186","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:176500","disease_name":"Cerebral amyloid angiopathy, itm2b-related, 1","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"OMIM:176500","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"4c3c45580e6fb60b980694eece70b550f9d0a8db2b41086ba497667b2d2eb22f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:176500","disease_name":"Cerebral amyloid angiopathy, itm2b-related, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002344","is_excluded":false,"label":"Progressive neurologic deterioration","onset_id":null,"reference":"OMIM:176500","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"6f08183c3d5521dc1e9bc7ce23cb28839323905f0dd9450de6a4bc7f30e50950","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:176500","disease_name":"Cerebral amyloid angiopathy, itm2b-related, 1","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000726","is_excluded":false,"label":"Dementia","onset_id":null,"reference":"OMIM:176500","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"96868213aef50d4da1c124d720d7cb63ede2eb8d42765460ee32b6af4c5da7b6","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:176500","disease_name":"Cerebral amyloid angiopathy, itm2b-related, 1","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0011970","is_excluded":false,"label":"Cerebral amyloid angiopathy","onset_id":null,"reference":"OMIM:176500","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"b86dcc4e8623f2ae3c016dbfc26bb3c87b9b34d0f020520c295eca27f47454ae","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:176500","disease_name":"Cerebral amyloid angiopathy, itm2b-related, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001276","is_excluded":false,"label":"Hypertonia","onset_id":null,"reference":"OMIM:176500","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"cfdf0c7df94f849c19aa83e2e161c21d5cc1acbe3155cc2b6c060203be352617","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:176500","disease_name":"Cerebral amyloid angiopathy, itm2b-related, 1","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002063","is_excluded":false,"label":"Rigidity","onset_id":null,"reference":"OMIM:176500","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/8344\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0008306\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0008306</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A cerebral amyloid angiopathy characterized by onset in the 4th to 6th decade of life, progressive mental deterioration, spasticity, muscular rigidity but no tremors, spontaneous movements or sensory changes that has material basis in an autosomal dominant mutation of ITM2B on chromosome 13q14.2.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/8344\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"abri-amyloidosis","sourceDocuments":[{"name":"GARD: ABri amyloidosis","reviewed":null,"source_release":"2026-10-21T17:06:16Z","url":"https://rarediseases.info.nih.gov/diseases/8344"},{"name":"MONDO: ABri amyloidosis","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0008306"}],"sourceNote":"","synonyms":["ABri amyloidosis","Bri amyloidosis","cerebral amyloid angiopathy, British type","cerebral amyloid angiopathy, ITM2B-related, type 1","dementia familial British","familial dementia, British type","FBD","presenile dementia with spastic ataxia"],"takeawayHtml":"","title":"ABri amyloidosis"},"schemaVersion":1}
